Chondrocyte BMP2 signaling plays an essential role in bone fracture healing

Gene

Volumn 512, Issue 2, 2013, Pages 211-218

  Mi, Meng ^a,b   Jin, Hongting ^a,c   Wang, Baoli ^a,d   Yukata, Kiminori ^a   Sheu, Tzong jen ^a   Ke, Qiao Han ^e   Tong, Peijian ^c   Im, Hee Jeong ^e   Xiao, Guozhi ^e   Chen, Di ^a,e  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Beijing Jishuitan Hospital   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BMP2; Chondrocyte; Conditional knockout; Fracture callus; Fracture healing; Osteoblast

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE MINERALIZATION; BONE RADIOGRAPHY; CALLUS; CARTILAGE CELL; CONTROLLED STUDY; FRACTURE HEALING; HISTOPATHOLOGY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TIBIA FRACTURE; X RAY ANALYSIS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONY CALLUS; CALCIFICATION, PHYSIOLOGIC; CHONDROCYTES; FRACTURE HEALING; FRACTURES, BONE; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; X-RAY MICROTOMOGRAPHY;

MUS;

EID: 84870309770     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.130     Document Type: Article

References (47)

1. Baltzer A.W., et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther. 2000, 7(9):734-739.
2. Bertone A.L., et al. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J. Orthop. Res. 2004, 22(6):1261-1270.
3. Bolander M.E. Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med. 1992, 200(2):165-170.
4. Borovecki F., Pecina-Slaus N., Vukicevic S. Biological mechanisms of bone and cartilage remodeling-genomic perspective. Int. Orthop. 2007, 31(6):799-805.
5. Cheng H., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. Am. 2003, 85-A(8):1544-1552.
6. Chung U.I., et al. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest. 2001, 107(3):295-304.
7. Cook S.D., et al. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. Relat. Res. 1994, 301:302-312.
8. Dacquin R., et al. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn. 2002, 224(2):245-251.
9. Einhorn T.A., et al. The expression of cytokine activity by fracture callus. J. Bone Miner. Res. 1995, 10(8):1272-1281.
10. Gazit D., et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J. Gene Med. 1999, 1(2):121-133.
11. Govender S., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 2002, 84-A(12):2123-2134.
12. Hanada K., et al. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 1997, 12(10):1606-1614.
13. Hanada K., et al. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J. Cell. Biochem. 2001, 81(2):284-294.
14. Hasharoni A., et al. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J. Neurosurg. Spine 2005, 3(1):47-52.
15. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996, 10(13):1580-1594.
16. Huang Y.H., et al. Bone morphogenetic proteins and osseointegration: current knowledge - future possibilities. Periodontol. 2000 2008, 2000(47):206-223.
17. Kallai I.V., et al. Quantitative, structural, and image-based mechanical analysis of nonunion fracture repaired by genetically engineered mesenchymal stem cells. J. Biomech. 2010, 43(12):2315-2320.
18. Kawabata M., Miyazono K. Signal transduction of the TGF-beta superfamily by Smad proteins. J. Biochem. 1999, 125(1):9-16.
19. Kloen P., et al. Expression and activation of the BMP-signaling components in human fracture nonunions. J. Bone Joint Surg. Am. 2002, 84-A(11):1909-1918.
20. Kloen P., et al. BMP signaling components are expressed in human fracture callus. Bone 2003, 33(3):362-371.
21. Kugimiya F., et al. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J. Biol. Chem. 2005, 280(42):35704-35712.
22. Kwong F.N., et al. Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion. J. Orthop. Res. 2009, 27(6):752-757.
23. Lieberman J.R., et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 1999, 81(7):905-917.
24. Lou J., et al. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 1999, 17(1):43-50.
25. Morgan E.F., et al. Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 2009, 44(2):335-344.
26. Otsuka F., et al. Bone morphogenetic protein-15. Identification of target cells and biological functions. J. Biol. Chem. 2000, 275(50):39523-39528.
27. Ovchinnikov D.A., et al. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 2000, 26(2):145-146.
28. Parfitt A.M., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 1987, 2(6):595-610.
29. Schmidmaier G., et al. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 2002, 30(6):816-822.
30. Sheyn D., et al. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion. Stem Cells 2008, 26(4):1056-1064.
31. Shu B., et al. BMP2, but not BMP4, is critical for chondrocyte proliferation and maturation during endochondral bone development. J. Cell Sci. 2011, 124(Pt. 20):3428-3440.
32. Simic P., Vukicevic S. Bone morphogenetic proteins: from developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Rep. 2007, 8(4):327-331.
33. Simmons D.J. Fracture healing perspectives. Clin. Orthop. Relat. Res. 1985, 200:100-113.
34. Spector J.A., et al. Expression of bone morphogenetic proteins during membranous bone healing. Plast. Reconstr. Surg. (1946) 2001, 107(1):124-134.
35. Takeda S., et al. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 2001, 15(4):467-481.
36. Thies R.S., et al. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992, 130(3):1318-1324.
37. Tsuji K., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 2006, 38(12):1424-1429.
38. Tsuji K., et al. BMP4 is dispensable for skeletogenesis and fracture-healing in limb. J. Bone Joint Surg. Am. 2008, 90(Suppl. 1):14-18.
39. Turgeman G., et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J. Gene Med. 2001, 3(3):240-251.
40. White A.P., et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int. Orthop. 2007, 31(6):735-741.
41. Wozney J.M., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242(4885):1528-1534.
42. Yasko A.W., et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): a radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. Am. 1992, 74(5):659-670.
43. Yu Y.Y., et al. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 2010, 46(3):841-851.
44. Zachos T.A., Shields K.M., Bertone A.L. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. J. Orthop. Res. 2006, 24(6):1279-1291.
45. Zapf J., et al. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J. Clin. Invest. 1986, 77(6):1768-1775.
46. Zegzula H.D., et al. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. Am. 1997, 79(12):1778-1790.
47. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorionic and cardiac development. Development 1996, 122(10):2977-2986.